News|Podcasts|September 8, 2023
Episode 97: Identifying Gaps in Access to Parkinson Disease Care
Author(s)Marco Meglio
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with James Beck, PhD. [LISTEN TIME: 15 minutes]
Advertisement
Episode 97 of the NeurologyLive® Mind Moments ® podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.
The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.
Episode 97, "Identifying Gaps in Access to Parkinson Disease Care" Features an interview with James Beck, PhD, senior vice president and chief scientific officer of the Parkinson's Foundation. Beck provided perspective on a recently published Medicare claims study that highlighted major gaps and disparities in access to Parkinson disease care. He spoke on the significance of the findings, including the lack of movement disorder specialists and issues with access to mental health professionals despite high rates of depression in this patient population. Furthermore, he spoke on the ways to make specialized care for Parkinson disease more obtainable, especially for those in rural or underserved communities.
This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
FDA Approves Sandoz’s Natalizumab-sztn as First Biosimilar for Multiple Sclerosis Duchenne Agent Pamrevlumab Fails to Meet Primary End Point in Phase 3 LELANTOS-2 Trial FDA Issues Ravulizumab Complete Response Letter for NMOSD, Citing Needed Changes to REMS Program
EPISODE BREAKDOWN
- 1:15 – Overview of Medicare study and objectives
- 2:20 – Greatest clinical take-home points from the data
- 4:15 – Utilizing resources to cover gaps in access
- 5:30 – Neurology News Minute
- 8:05 – Reasons for lack of mental health professional support
- 10:55 – Challenges with understanding depression in PD
- 12:35 – Ensuring access to PD care in rural/underserved communities
Hoping to listen on your favorite podcast app? See below:
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
NeurologyLive® Friday 5 — September 12, 2025September 12th 2025
Expanding the Alzheimer Drug Development PipelineSeptember 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Enhancing Gene Therapy Safety for Duchenne Through New Recommendations: Barry Byrne, MD, PhD
2
Expanding the Alzheimer Drug Development Pipeline
3
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
4
Patient-Reported Study Identifies Common Symptoms and Timing During Migraine Prodrome
5
